Haemonetics Financial Statements From 2010 to 2026

Haemonetics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 42.5 M 45.7 M 51.1 M Slightly volatile Total Assets 3 B 2.8 B 1.6 B Slightly volatile Short and Long Term Debt Total 1.5 B 1.4 B 611 M Slightly volatile Other Current Liabilities 198.3 M 188.8 M 112 M Slightly volatile Total Current Liabilities 698.1 M 664.8 M 307.9 M Slightly volatile Total Stockholder Equity 546.7 M 944 M 723.4 M Slightly volatile Property Plant And Equipment Net 189.6 M 326.7 M 270.8 M Slightly volatile Retained Earnings 285 M 405 M 284.6 M Very volatile Accounts Payable 80.9 M 77 M 54.1 M Slightly volatile Cash 370.4 M 352.8 M 203 M Slightly volatile Non Current Assets Total 1.8 B 1.7 B 980.6 M Slightly volatile Non Currrent Assets Other 101.3 M 188.7 M 174.3 M Slightly volatile Cash And Short Term Investments 370.4 M 352.8 M 203 M Slightly volatile Net Receivables 123.7 M 233.1 M 158.4 M Slightly volatile Liabilities And Stockholders Equity 3 B 2.8 B 1.6 B Slightly volatile Non Current Liabilities Total 1.3 B 1.2 B 583.4 M Slightly volatile Inventory 440.9 M 419.9 M 243.9 M Slightly volatile Other Current Assets 52.6 M 69.5 M 60 M Pretty Stable Other Stockholder Equity 631.8 M 601.8 M 485.5 M Slightly volatile Total Liabilities 2 B 1.9 B 891.3 M Slightly volatile Property Plant And Equipment Gross 1 B 962.8 M 500.2 M Slightly volatile Total Current Assets 1.1 B 1.1 B 660.3 M Slightly volatile Short Term Debt 366.5 M 349.1 M 105.7 M Slightly volatile Intangible Assets 550.3 M 524.1 M 268.9 M Slightly volatile Common Stock Total Equity 421 K 579.6 K 480.6 K Slightly volatile Common Stock 423.5 K 554.3 K 480 K Slightly volatile Other Liabilities 131.1 M 124.9 M 64.5 M Slightly volatile Other Assets 1.1 K 1.1 K 18.3 M Pretty Stable Long Term Debt 1.1 B 1.1 B 500 M Slightly volatile Good Will 729.7 M 694.9 M 366.8 M Slightly volatile Property Plant Equipment 226.7 M 381.3 M 284.6 M Slightly volatile Retained Earnings Total Equity 230.9 M 227.9 M 277.5 M Slightly volatile Long Term Debt Total 1.1 B 1.1 B 497.8 M Slightly volatile Capital Surpluse 532.6 M 601.8 M 494 M Slightly volatile Deferred Long Term Liabilities 26.4 M 41.6 M 26.6 M Slightly volatile Non Current Liabilities Other 57 M 78.4 M 53.7 M Slightly volatile Deferred Long Term Asset Charges 3.3 M 5 M 3.6 M Slightly volatile Short and Long Term Debt 286.9 M 273.2 M 193.7 M Slightly volatile Cash And Equivalents 225.9 M 352.8 M 192 M Slightly volatile Net Invested Capital 1.2 B 2.4 B 1.2 B Slightly volatile Net Working Capital 399.1 M 410.4 M 274.6 M Slightly volatile Capital Stock 403.1 K 433.8 K 496.7 K Slightly volatile Capital Lease Obligations 6.2 M 6.5 M 41.5 M Slightly volatile
Haemonetics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Total Revenue 1.6 B 1.6 B 1 B Slightly volatile Gross Profit 940.1 M 895.3 M 521.6 M Slightly volatile EBIT 298.4 M 284.2 M 129.3 M Slightly volatile EBITDA 429.9 M 409.4 M 214.8 M Slightly volatile Depreciation And Amortization 131.5 M 125.2 M 85.9 M Slightly volatile Other Operating Expenses 1.4 B 1.3 B 913.5 M Slightly volatile Cost Of Revenue 336.1 M 669.6 M 472.7 M Slightly volatile Total Operating Expenses 672.3 M 640.2 M 419.2 M Slightly volatile Research Development 83.8 M 79.8 M 51.6 M Slightly volatile Selling General Administrative 240.4 M 476.5 M 309.3 M Slightly volatile Selling And Marketing Expenses 5.1 M 8.9 M 4.9 M Slightly volatile Non Recurring 630.4 K 663.5 K 19.3 M Pretty Stable Interest Income 13.2 M 11.2 M 11.3 M Slightly volatile Reconciled Depreciation 109.6 M 132.9 M 97.9 M Slightly volatile
Haemonetics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 172 M 163.8 M 86.2 M Slightly volatile Begin Period Cash Flow 132.1 M 205.6 M 173.8 M Slightly volatile Depreciation 139.6 M 132.9 M 90.6 M Slightly volatile Capital Expenditures 54 M 45.2 M 70.1 M Very volatile Total Cash From Operating Activities 109.7 M 209 M 149.5 M Slightly volatile End Period Cash Flow 370.4 M 352.8 M 203 M Slightly volatile Change To Netincome 40.4 M 41.6 M 38.4 M Pretty Stable
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.14 3.2843 2.3812 Pretty Stable Dividend Yield 0.0098 0.011 0.012 Slightly volatile PTB Ratio 2.81 4.4787 3.8474 Pretty Stable Days Sales Outstanding 77.02 57.5951 55.8803 Slightly volatile Book Value Per Share 19.88 18.9319 16.6734 Slightly volatile Free Cash Flow Yield 0.0239 0.0269 0.0425 Slightly volatile Operating Cash Flow Per Share 3.76 3.5844 3.6179 Slightly volatile Stock Based Compensation To Revenue 0.0141 0.0216 0.0213 Slightly volatile Capex To Depreciation 1.26 0.682 0.4141 Slightly volatile PB Ratio 2.81 4.4787 3.8474 Pretty Stable EV To Sales 2.22 3.7648 3.0094 Very volatile Free Cash Flow Per Share 2.39 2.2769 2.7718 Slightly volatile ROIC 0.0879 0.067 0.0802 Pretty Stable Inventory Turnover 2.92 1.9467 1.7648 Slightly volatile Net Income Per Share 2.43 2.3184 3.219 Slightly volatile Days Of Inventory On Hand 119 187 210 Slightly volatile Payables Turnover 8.05 8.4177 9.0267 Slightly volatile Sales General And Administrative To Revenue 0.37 0.3244 0.3415 Slightly volatile Research And Ddevelopement To Revenue 0.0565 0.0416 0.0464 Pretty Stable Capex To Revenue 0.0875 0.0506 0.0336 Slightly volatile Cash Per Share 2.1 3.5262 5.7089 Slightly volatile POCF Ratio 14.71 23.6552 17.6988 Pretty Stable Interest Coverage 12.03 12.6658 21.5349 Slightly volatile Payout Ratio 0.19 0.22 0.2349 Slightly volatile Capex To Operating Cash Flow 0.62 0.3648 0.2486 Slightly volatile PFCF Ratio 39.65 37.2384 24.2228 Slightly volatile Days Payables Outstanding 43.29 43.3609 40.3624 Slightly volatile Income Quality 1.47 1.5461 1.1337 Slightly volatile ROE 0.11 0.1225 0.1939 Slightly volatile EV To Operating Cash Flow 15.31 27.116 22.395 Pretty Stable PE Ratio 26.18 36.5723 20.4268 Slightly volatile Return On Tangible Assets 0.0843 0.096 0.117 Slightly volatile EV To Free Cash Flow 41.98 42.6864 30.3668 Slightly volatile Earnings Yield 0.0342 0.0273 0.0501 Slightly volatile Intangibles To Total Assets 0.46 0.4423 0.4347 Slightly volatile Net Debt To EBITDA 2.49 2.3684 2.6865 Slightly volatile Current Ratio 3.21 2.5597 1.7664 Slightly volatile Receivables Turnover 4.25 6.3373 6.5477 Slightly volatile Graham Number 33.0 31.4257 34.6411 Slightly volatile Shareholders Equity Per Share 19.88 18.9319 16.6734 Slightly volatile Debt To Equity 0.88 0.8415 1.4178 Slightly volatile Capex Per Share 0.76 1.3075 0.8102 Slightly volatile Revenue Per Share 27.11 25.8166 26.9704 Slightly volatile Interest Debt Per Share 17.0 16.1877 23.5953 Slightly volatile Debt To Assets 0.39 0.3679 0.4855 Slightly volatile Enterprise Value Over EBITDA 12.27 18.5572 12.5312 Slightly volatile Short Term Coverage Ratios 14.21 17.7682 2.4093 Slightly volatile Price Earnings Ratio 26.18 36.5723 20.4268 Slightly volatile Operating Cycle 175 245 265 Slightly volatile Price Book Value Ratio 2.81 4.4787 3.8474 Pretty Stable Price Earnings To Growth Ratio 17.43 16.6038 2.3942 Slightly volatile Days Of Payables Outstanding 43.29 43.3609 40.3624 Slightly volatile Dividend Payout Ratio 0.19 0.22 0.2349 Slightly volatile Price To Operating Cash Flows Ratio 14.71 23.6552 17.6988 Pretty Stable Price To Free Cash Flows Ratio 39.65 37.2384 24.2228 Slightly volatile Pretax Profit Margin 0.12 0.116 0.1514 Slightly volatile Ebt Per Ebit 0.78 0.921 0.9436 Slightly volatile Operating Profit Margin 0.13 0.126 0.1589 Slightly volatile Effective Tax Rate 0.32 0.2259 0.2168 Slightly volatile Company Equity Multiplier 1.34 2.2872 2.848 Slightly volatile Long Term Debt To Capitalization 0.48 0.4538 0.5215 Slightly volatile Total Debt To Capitalization 0.48 0.457 0.5834 Slightly volatile Return On Capital Employed 0.14 0.087 0.1179 Very volatile Debt Equity Ratio 0.88 0.8415 1.4178 Slightly volatile Ebit Per Revenue 0.13 0.126 0.1589 Slightly volatile Quick Ratio 2.3 1.5038 1.0935 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.78 2.7415 4.3483 Slightly volatile Net Income Per E B T 0.44 0.7741 0.7691 Slightly volatile Cash Ratio 0.71 0.5952 0.545 Slightly volatile Cash Conversion Cycle 143 202 225 Slightly volatile Operating Cash Flow Sales Ratio 0.13 0.1388 0.1336 Very volatile Days Of Inventory Outstanding 119 187 210 Slightly volatile Days Of Sales Outstanding 77.02 57.5951 55.8803 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.35 0.6352 0.7496 Slightly volatile Cash Flow Coverage Ratios 0.21 0.225 0.1565 Slightly volatile Price To Book Ratio 2.81 4.4787 3.8474 Pretty Stable Fixed Asset Turnover 4.18 3.5705 4.6831 Slightly volatile Capital Expenditure Coverage Ratio 1.78 2.7415 4.3483 Slightly volatile Price Cash Flow Ratio 14.71 23.6552 17.6988 Pretty Stable Enterprise Value Multiple 12.27 18.5572 12.5312 Slightly volatile Debt Ratio 0.39 0.3679 0.4855 Slightly volatile Cash Flow To Debt Ratio 0.21 0.225 0.1565 Slightly volatile Price Sales Ratio 2.14 3.2843 2.3812 Pretty Stable Return On Assets 0.0694 0.0535 0.0676 Slightly volatile Asset Turnover 0.88 0.5962 0.5767 Slightly volatile Net Profit Margin 0.0834 0.0898 0.1189 Slightly volatile Gross Profit Margin 0.57 0.5283 0.5502 Very volatile Price Fair Value 2.81 4.4787 3.8474 Pretty Stable Return On Equity 0.11 0.1225 0.1939 Slightly volatile
Haemonetics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2 B 1.9 B 1.9 B Slightly volatile Enterprise Value 2.1 B 2 B 2 B Slightly volatile

Haemonetics Fundamental Market Drivers

Haemonetics Upcoming Events

About Haemonetics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:

How To Invest In Haemonetics Details

Is Haemonetics Stock a good investment? Details

What is Haemonetics' Net Worth? Details

Largest Health Care Equipment & Supplies Companies View

Largest Health Care Equipment & Services Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details